Matt Lester Baum, D.Phil., M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ethylene Glycols | 1 | 2016 | 156 | 0.540 |
Why?
|
Off-Label Use | 1 | 2016 | 169 | 0.510 |
Why?
|
Fluorine Radioisotopes | 1 | 2016 | 442 | 0.450 |
Why?
|
Psychiatry | 2 | 2023 | 1695 | 0.450 |
Why?
|
Persuasive Communication | 1 | 2012 | 59 | 0.410 |
Why?
|
Aniline Compounds | 1 | 2016 | 986 | 0.400 |
Why?
|
Personal Autonomy | 1 | 2012 | 298 | 0.340 |
Why?
|
Mental Disorders | 4 | 2023 | 6600 | 0.340 |
Why?
|
Policy Making | 1 | 2012 | 554 | 0.310 |
Why?
|
Choice Behavior | 1 | 2012 | 803 | 0.270 |
Why?
|
Risk Reduction Behavior | 1 | 2012 | 1125 | 0.250 |
Why?
|
Ethicists | 1 | 2022 | 37 | 0.220 |
Why?
|
Motivation | 1 | 2012 | 1971 | 0.200 |
Why?
|
Prostate-Specific Antigen | 1 | 2011 | 2494 | 0.200 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2011 | 66 | 0.190 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6234 | 0.190 |
Why?
|
Health Behavior | 1 | 2012 | 2636 | 0.180 |
Why?
|
Morals | 1 | 2022 | 284 | 0.170 |
Why?
|
Health Policy | 1 | 2012 | 2661 | 0.170 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3229 | 0.160 |
Why?
|
Clozapine | 1 | 2021 | 498 | 0.160 |
Why?
|
Early Detection of Cancer | 1 | 2011 | 3086 | 0.150 |
Why?
|
Incidental Findings | 1 | 2022 | 689 | 0.150 |
Why?
|
Aging | 1 | 2016 | 8664 | 0.150 |
Why?
|
Alzheimer Disease | 1 | 2016 | 8037 | 0.130 |
Why?
|
Complement C4 | 1 | 2016 | 257 | 0.130 |
Why?
|
Brain | 5 | 2018 | 26385 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5319 | 0.110 |
Why?
|
Treatment Refusal | 1 | 2016 | 421 | 0.110 |
Why?
|
Schizophrenia | 2 | 2021 | 6882 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1708 | 0.090 |
Why?
|
Cell Lineage | 1 | 2018 | 2504 | 0.090 |
Why?
|
Calpain | 1 | 2009 | 150 | 0.080 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11124 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13695 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2021 | 3057 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2183 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3617 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 895 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5137 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2518 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Ethics Committees, Research | 1 | 2023 | 194 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12959 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2011 | 1622 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6544 | 0.050 |
Why?
|
Bioethical Issues | 1 | 2020 | 124 | 0.040 |
Why?
|
Research Personnel | 1 | 2023 | 573 | 0.040 |
Why?
|
Humans | 10 | 2023 | 744343 | 0.040 |
Why?
|
Social Isolation | 1 | 2020 | 365 | 0.040 |
Why?
|
Complement Pathway, Classical | 1 | 2016 | 97 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
Social Stigma | 1 | 2020 | 701 | 0.030 |
Why?
|
Synapses | 2 | 2016 | 1728 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Dendrites | 1 | 2016 | 485 | 0.030 |
Why?
|
Major Histocompatibility Complex | 1 | 2016 | 936 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1252 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2050 | 0.020 |
Why?
|
Dimerization | 1 | 2011 | 893 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2779 | 0.020 |
Why?
|
Models, Animal | 1 | 2016 | 2171 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2009 | 112 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 480 | 0.020 |
Why?
|
Axons | 1 | 2016 | 1684 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 489 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2011 | 1801 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2016 | 1422 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 697 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7785 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
Mental Health | 1 | 2020 | 3019 | 0.020 |
Why?
|
Endocytosis | 1 | 2009 | 985 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6933 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2009 | 1117 | 0.010 |
Why?
|
Mice | 3 | 2018 | 81183 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13815 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1706 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2009 | 1169 | 0.010 |
Why?
|
Protein Conformation | 1 | 2011 | 4011 | 0.010 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9438 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 13033 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8436 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Animals | 3 | 2018 | 168757 | 0.010 |
Why?
|
Male | 2 | 2018 | 350118 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 8301 | 0.010 |
Why?
|
Female | 1 | 2016 | 380194 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12072 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15519 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14557 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19229 | 0.010 |
Why?
|
Rats | 1 | 2009 | 24260 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
Neurons | 1 | 2009 | 9338 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|